Home > Healthcare > Medical Devices > Infection Control > Reprocessed Medical Devices Market
Reprocessed Medical Devices Market size was worth over USD 2 billion in 2022 and is estimated to record 16.9% CAGR from 2023 to 2032 attributed to the presence of favorable regulatory landscape associated with sustainable waste disposal methods.
Several favorable policies for sustainable hospital waste disposal systems have been implemented in response to the increasing environmental concerns. The economic and environmental advantages of recycling medical equipment have been acknowledged by several governments and healthcare organizations worldwide. Additionally, multiple government agencies are launching numerous programs to assist the growth of the medical devices sector, further fueling the market expansion. For instance, the National Medical Devices Policy 2023 in India intends to set the medical devices industry on an expedited path of growth with a patient-centric strategy to fulfill the patients' changing healthcare demands.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Reprocessed Medical Devices Market Size in 2022: | USD 2.1 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 16.9% |
2032 Value Projection: | USD 10.2 billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 220 |
Tables, Charts & Figures: | 499 |
Segments covered: | Product, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The rising concerns of infection and pathogenic agent transmission among patients in healthcare settings caused by reprocessed surgical equipment may hamper the industry growth to some extent. Most surgical site infections (SSI) are brought on by contaminated environments, inappropriate medical equipment reprocessing, and cross-infection in these devices. However, standards and practices for safe reprocessing are specified to eliminate these hazards. Inadequate reprocessing of surgical equipment, such as flexible duodenoscopes and arthroscopic shavers have also resulted in high infection rates, limiting the product adoption.
The COVID-19 pandemic had an adverse effect on the medical device sector since it caused several regulatory bodies all around the world to delay regulatory clearance. The halted industrial operations also slowed down the market progress. However, with the improving pandemic circumstances worldwide, more people are choosing to utilize reprocessed medical equipment to save money, further promoting the market expansion. For instance, the AMDR research states that U.S. hospitals saved $372 million in 2020, merely by reprocessing single-use medical equipment since they are 25% to 40% less expensive than new ones.
The affordable costs of reprocessed medical devices coupled with the strengthening network of distributors in emerging economies will support the market growth. Several innovations in reprocessing technologies and techniques have improved the safety, efficacy, and quality of reprocessed devices. Advanced sterilization methods and rigorous testing protocols are also ensuring that reprocessed devices meet or exceed regulatory standards, further instilling confidence in healthcare professionals and patients. Moreover, rising advancements are expanding the range of medical devices that can be reprocessed, including complex instruments and single-use devices. The jump in such technological breakthroughs for not only enhancing the patient safety but also contributing to cost savings will surge the product demand.
Reprocessed cardiovascular medical devices market generated USD 1.1 billion in revenue in 2022 and is estimated to expand at notable CAGR from 2023-2032 driven by the rising prevalence of cardiovascular diseases and the surge in the number of treatment procedures. As cardiovascular procedures are expensive, several market players are taking efforts to introduce affordable reprocessed devices in healthcare facilities to reduce costs without compromising patient care. For instance, in June 2023, Vein360, a medical technology company in Ohio, received FDA 510(k) approval for reprocessing the Visions PV.035 digital intravascular ultrasound catheter (Philips).
The hospitals segment in the reprocessed medical devices market is estimated to grow at 17% CAGR from 2023-2032. The growth can be attributed to consistent patient care, as well as cost and environmental benefits rendered by reprocessed medical equipment. Additionally, the growing emphasis of hospitals on various methods to save healthcare costs have compelled multiple manufacturers, distributors, and third-party companies to initiate reprocessing efforts to help with medical equipment. The growing prospects for reprocessed medical device businesses in emerging economies for significant unmet demands will enhance the segment expansion.
North America reprocessed medical devices market size is poised to exceed USD 4.5 billion by 2032. Several hospitals and healthcare institutions in the region are resorting to reprocessed equipment as a cost-saving solution in response to the mounting need to reduce healthcare expenses. According to a report published by the Association of Medical Device Reprocessors in 2022, the adoption of reprocessed single-use medical devices may help U.S. hospitals save up to $2.28 billion annually. Furthermore, the higher implementation of stringent regulatory criteria by health authorities as well as the rising sustainability concerns in the healthcare sector will surge the adoption of reprocessed medical equipment throughout the region.
Some of the major market players operating in the reprocessed medical devices market are
Click here to Buy Section of this Report
By Product, 2018 - 2032 (USD Million)
By End-use, 2018 - 2032 (USD Million)
The above information is provided for the following regions and countries: